Tag Cloud
assays biology domain biomarker exchange biomedical DMRs business models cloud computing collaboration combine compression algorithms conferences CROs data and model resources ethical hacking externalization hosted services IMI information ecosystem innovation knowledge brokering meetings membership next-generation sequencing OData ontologies open data formats open source presentations proofs of concept publications query services RDF rfps SaaS scientific publishing security sequence services sequence squeeze SESL SPARQL standards translational medicine vox pistoia VPH webinars workshopsRecent Comments
- Application Security: Getting the Most from Your Assessment | INSIGHTS from Pistoia Alliance on Application Security: How Modern Hackers Hack
- Sequence Squeeze Entrants: fqzcomp and sam_comp | INSIGHTS from Pistoia Alliance on Sequence Squeeze Entrants: Quip
- James McGurk on Do Biomarker Exchange Standards Exist?
- Bryn Williams-Jones on Do Biomarker Exchange Standards Exist?
- Do Biomarker Exchange Standards Exist? | INSIGHTS from Pistoia Alliance on Kicking Off New Working Groups
Author Archives: Nick Lynch
Posted on February 24, 2012 by Nick Lynch
So what is the face-to-face meeting of the Pistoia Alliance Board and Operational Team that Michael referred to in his latest entries? It’s ironic—when we held the first such meeting in 2010, it garnered a meaty story in BioITWorld. We … Continue reading →
Posted in Alliance news & milestones, Collaboration & community
|
Tagged bioitworld, conferences, meetings, membership
|
Leave a comment
Posted on November 17, 2011 by Nick Lynch
Robert Mitchell over at Computerworld recently blogged about his takeaways from the Gartner Symposium/ITxpo. He nailed it, I think, raising themes that we’ve definitely noticed here at the Pistoia Alliance. We’re also thrilled he gave us a mention in his … Continue reading →
Posted in Collaboration & community
|
Tagged cloud computing, innovation, knowledge brokering
|
Leave a comment
Posted on September 1, 2011 by Nick Lynch
I’m thrilled that Collaborative Drug Discovery has chosen to renew its annual membership with us. Of course, I’d like to hear more about why CDD ultimately decided to renew given the reservations expressed in this blog entry about Pistoia being … Continue reading →
Posted in Collaboration & community, Workflows & business processes
|
Tagged business models, collaboration, innovation, membership
|
2 Comments
Posted on August 16, 2011 by Nick Lynch
A few weeks ago, Drug Discovery World published our article on obstacles to innovation in pharma, which was informed by a great conversation on this blog in May. We concluded that the fundamental obstacles to innovation reside in pharma’s inability … Continue reading →
Posted in Collaboration & community, Workflows & business processes
|
Tagged innovation, publications
|
Leave a comment
Posted on May 13, 2011 by Nick Lynch
Drug Discovery World wants to know and has asked the Pistoia Alliance to submit an article next month on this subject. And while we have some ideas already, we’d love to open this question to the floor. What do you … Continue reading →
Posted in Collaboration & community, Workflows & business processes
|
Tagged innovation, publications
|
9 Comments